Advancements and Controversies in Biotech

Guest: Over the past few weeks some really exciting papers came out describing the reprogramming of one cell into another, a process called Direct Reprogramming.  On this episode we talk to Dr. Justin Ichida from the University of Southern California who uses the latest reprogramming techniques in his lab to study neural disease. His current research is focused on using patient-specific disease models to define the mechanisms that lead to neuronal loss in ALS and frontotemporal dementia. Resources and Links University of Southern California - The Ichida Lab – Board California Institute for Regenerative Medicine (CIRM) Center for Regenerative Medicine and Stem Cell Research Early Treatment Is Found to Clear H.I.V. in a Second Baby Why Can You Remember Your Dreams? Researchers Uncover Why Only Some People Can Recall Them in the Morning Acetaminophen In Pregnancy Linked to ADHD in Kids, Study Finds Study Uncovers New Pathway of Melanoma Metastasis New Research Finds Direct Connection Between Acupuncture and Processes That Alleviate Sepsis 'Largest Ever' Trial of Adult Stem Cells in Heart Attack Patients Begins This Company Wants to Make In Vitro Meat From Celebrities’ Stem Cells USPTO Issues Patent For Fraudulent Stem Cell Procedure Isolation Of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors By Cell Sorting For Successful Transplantation Coordination Of Engineered Factors With TET1/2 Promotes Early-Stage Epigenetic Modification during Somatic Cell Reprogramming Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming Photo Reference: Courtesy of Dr. Justin Ichida Subscribe to our newsletter! Never miss updates about new episodes. Subscribe